Phillips, Gail Lewis,Sampath, Deepak,Wertz, Ingrid
申请号：
HRP20191019
公开号：
HRP20191019T1
申请日:
2019.06.05
申请国别(地区):
HR
年份:
2019
代理人:
摘要：
The present invention is directed to a combination therapy involving an anti-HER2 antibody-drug conjugate and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a HER2-expressing cancer.
